{
  "actions": [
    {
      "acted_at": "2004-11-18", 
      "references": [
        {
          "reference": "CR S11497-11498", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2004-11-18", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2997-108", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "108", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2004-11-18", 
  "number": "2997", 
  "official_title": "A bill to amend section 1928 of the Social Security Act to encourage the production of influenza vaccines by eliminating the price cap applicable to the purchase of such vaccines under contracts entered into by the Secretary of Health and Human Services, to amend the Internal Revenue Code of 1986 to establish a tax credit to encourage vaccine production capacity, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Flu Vaccine Incentive Act of 2004", 
  "sponsor": {
    "district": null, 
    "name": "Inhofe, James M.", 
    "state": "OK", 
    "thomas_id": "00583", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2004-11-18", 
  "subjects": [
    "Child health", 
    "Commerce", 
    "Construction costs", 
    "Department of Health and Human Services", 
    "Drug industry", 
    "Economics and public finance", 
    "Families", 
    "Federal aid to research", 
    "Government operations and politics", 
    "Health", 
    "Income tax", 
    "Industrial buildings", 
    "Influenza", 
    "Investment tax credit", 
    "Medicaid", 
    "National Institutes of Health (NIH)", 
    "Pharmaceutical research", 
    "Prices", 
    "Research centers", 
    "Science, technology, communications", 
    "Social welfare", 
    "Taxation", 
    "Technological innovations", 
    "Vaccines"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2004-11-18", 
    "text": "Flu Vaccine Incentive Act of 2004 or FLU-VIA - Amends title XIX (Medicaid) of the Social Security Act to exempt contracts entered into by the Secretary of Health and Human Services for the purchase of a pediatric influenza vaccine and other vaccines from certain price restrictions applicable to such contracts. Extends such exemption to any other Federal agency that purchases an influenza vaccine. Amends the Internal Revenue Code to allow a tax credit for investment in influenza vaccine manufacturing facilities. Expresses the sense of the Senate supporting increased funding to develop new technologies for the production of influenza vaccines."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Flu Vaccine Incentive Act of 2004", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "FLU-VIA", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend section 1928 of the Social Security Act to encourage the production of influenza vaccines by eliminating the price cap applicable to the purchase of such vaccines under contracts entered into by the Secretary of Health and Human Services, to amend the Internal Revenue Code of 1986 to establish a tax credit to encourage vaccine production capacity, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:33:03-05:00"
}